<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Medicine</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/FD6A1B62-365B-4829-97F2-46670524E531"><gtr:id>FD6A1B62-365B-4829-97F2-46670524E531</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>Michael</gtr:otherNames><gtr:surname>Lever</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800142"><gtr:id>8C79772A-F96D-44AE-A2FC-003F0BD678D5</gtr:id><gtr:title>Structural and functional studies in lentivirus RNA encapsidation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800142</gtr:grantReference><gtr:abstractText>There is no vaccine for HIV/AIDS. Drug combinations slow the virus but it has developed resistance to all the current ones and new ones are needed which stop virus replication. When HIV assembles it packages its genes, which are on a long piece of RNA similar to our own DNA. There are lots of other RNAs in the cell and HIV recognises its own because this RNA folds up into a complex but distinct ?knot? like shape. The virus captures this RNA at a particular place inside the cell. Drugs blocking this process would provide a potentially very powerful new weapon against HIV. The plan is to deduce the structures of all the molecules involved and also where the capture happens so we can design antiviral molecules and get them to the correct place to work against the virus. The work will also have spin off benefits for gene therapy.</gtr:abstractText><gtr:technicalSummary>HIV, the causative agent of AIDS, is a retrovirus and during viral assembly it must identify and capture its capped, polyadenylated genomic RNA from the background excess of cellular RNAs and encapsidate it specifically. Ours and others? previous studies have given us considerable insight into this process at a structural and mechanistic level. It is a critical stage in the virus life cycle involving highly conserved RNA and protein motifs and hence is susceptible to therapeutic intervention. Packaging inhibitors would also potentially generate an element of autovaccinatory immune response against the host?s repertoire of viral variants. Packaging involves interaction of the Gag polyprotein of the virus with a conserved RNA structure (the packaging signal - psi). It is becoming clear that a number of cellular chaperone molecules are involved and that the RNA must travel along a very specific route in the cell, probably involving the centrosome, to be encapsidated efficiently. We will investigate the HIV genomic RNA packaging process. We will use novel chemical structural biological methods including oligonucleotide structure probing by FRET and two colour coincidence detection, to analyse:- three dimensional psi RNA structures, the changes in RNA structure involved in capture and the stoichiometry of Gag interactions with the RNA packaging signal. These will be combined with classical 2D (biochemical probing) and 3D (crystallography, NMR) methods and structural predictive methodology. We will also study the process of RNA capture within the cell, the pathway along which the RNA must travel to be encapsidated and the cellular chaperones involved. We will probe the molecular interactions involved with subcellular fractionation and mass spectroscopy and with siRNA knockdown. We will use targeted oligonucleotides to probe these interactions and confirm their importance and to identify therapeutic targets. These studies will unravel a critical process in HIV assembly which has a potentially high therapeutic index for antiviral intervention. We will also translate the findings into better design of lentiviral vectors which should enhance their efficiency and lead to better clinical tools for diagnostic and therapeutic uses.</gtr:technicalSummary><gtr:fund><gtr:end>2014-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1361243</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Interdisciplinary links with Dept of Chemistry</gtr:description><gtr:id>B8050983-4CD9-4063-A3E8-FE61866B2F27</gtr:id><gtr:impact>Milstein Grant from MRC</gtr:impact><gtr:outcomeId>5EC708D99B3-1</gtr:outcomeId><gtr:partnerContribution>Collaboration has resulted in award of a Milstein grant from the MRC</gtr:partnerContribution><gtr:piContribution>Identification of packaging signals in lentiviral RNA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Milstein award</gtr:description><gtr:end>2012-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>52FB67FF-EAE3-48F0-9840-AA7208746687</gtr:id><gtr:outcomeId>Ln75RiAcZSh0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2400554A-1B00-4423-8185-E83EEE4D12E2</gtr:id><gtr:title>Promoter optimisation of lentiviral vectors for efficient insulin gene expression in canine mesenchymal stromal cells: potential surrogate beta cells.</gtr:title><gtr:parentPublicationTitle>The journal of gene medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3f29e64eb61e21dd4abcccf74c28e1e"><gtr:id>f3f29e64eb61e21dd4abcccf74c28e1e</gtr:id><gtr:otherNames>Gautam P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1099-498X</gtr:issn><gtr:outcomeId>58aeb7450929e4.92970189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F245BA8B-E313-48F9-A87F-E7F70D5DB3E0</gtr:id><gtr:title>HIV-2 genome dimerization is required for the correct processing of Gag: a second-site reversion in matrix can restore both processes in dimerization-impaired mutant viruses.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bc884aa239160a2d44f740d3c8a61a8"><gtr:id>4bc884aa239160a2d44f740d3c8a61a8</gtr:id><gtr:otherNames>L'Hernault A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_12906_26_22419802</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B9B7483-74E6-4724-AD24-79551C8B447F</gtr:id><gtr:title>A novel combined RNA-protein interaction analysis distinguishes HIV-1 Gag protein binding sites from structural change in the viral RNA leader.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/604f916efba5cb5af8a2f429da5b435c"><gtr:id>604f916efba5cb5af8a2f429da5b435c</gtr:id><gtr:otherNames>Kenyon JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5675ec3ae1af4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F79ACDE8-BA0A-460E-9010-54D319521489</gtr:id><gtr:title>SHAPE analysis of the FIV Leader RNA reveals a structural switch potentially controlling viral packaging and genome dimerization.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/604f916efba5cb5af8a2f429da5b435c"><gtr:id>604f916efba5cb5af8a2f429da5b435c</gtr:id><gtr:otherNames>Kenyon JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>LLxkTvRX9xG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E76DC618-78CD-405C-AFE3-BC9DE55F9F3C</gtr:id><gtr:title>Insights into cellular factors that regulate HIV-1 replication in human cells.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17df4f22aab0306b360c42f283f05f57"><gtr:id>17df4f22aab0306b360c42f283f05f57</gtr:id><gtr:otherNames>Lever AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>pm_12906_26_21218853</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DCAC2CE-EAC0-461D-981D-28AC36F5018E</gtr:id><gtr:title>Evidence that the endosomal sorting complex required for transport-II (ESCRT-II) is required for efficient human immunodeficiency virus-1 (HIV-1) production.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26e2b0ef91980b521ba4025ee98b2093"><gtr:id>26e2b0ef91980b521ba4025ee98b2093</gtr:id><gtr:otherNames>Meng B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>56cf3cf148bee3.18163448</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FFD5A2F-905C-4496-8AE8-7ABA30EF431E</gtr:id><gtr:title>Current perspectives on RNA secondary structure probing.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/847d8542d534f25d0c4264305463efbd"><gtr:id>847d8542d534f25d0c4264305463efbd</gtr:id><gtr:otherNames>Kenyon J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>544e2b005a71f3.95926678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>251A0651-B205-4BC2-B230-E268D7D822D7</gtr:id><gtr:title>Rev regulates translation of human immunodeficiency virus type 1 RNAs.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1967f1ef6807f4bedadc0b6799a69e9a"><gtr:id>1967f1ef6807f4bedadc0b6799a69e9a</gtr:id><gtr:otherNames>Groom HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>D9ED990B170</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1AF0B19-E424-4123-91F5-9B65EC623C18</gtr:id><gtr:title>The molecular biology of feline immunodeficiency virus (FIV).</gtr:title><gtr:parentPublicationTitle>Viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/604f916efba5cb5af8a2f429da5b435c"><gtr:id>604f916efba5cb5af8a2f429da5b435c</gtr:id><gtr:otherNames>Kenyon JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1999-4915</gtr:issn><gtr:outcomeId>pm_12906_26_22163340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99A59181-0132-4524-B7E9-5B03CB8DF76A</gtr:id><gtr:title>In-gel probing of individual RNA conformers within a mixed population reveals a dimerization structural switch in the HIV-1 leader.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/604f916efba5cb5af8a2f429da5b435c"><gtr:id>604f916efba5cb5af8a2f429da5b435c</gtr:id><gtr:otherNames>Kenyon JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_12906_26_23935074</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDC97C1C-4F9E-4CB1-BEE6-14696A24E764</gtr:id><gtr:title>Characterizing 3D RNA structure by single molecule FRET.</gtr:title><gtr:parentPublicationTitle>Methods (San Diego, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9cf535aa7f0ef15eded27945b993d6a"><gtr:id>e9cf535aa7f0ef15eded27945b993d6a</gtr:id><gtr:otherNames>Stephenson JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1046-2023</gtr:issn><gtr:outcomeId>56cf3ca622e314.43166117</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F89FDEE-A33C-4C0F-853E-F5213A457526</gtr:id><gtr:title>Wrapping up the bad news: HIV assembly and release.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26e2b0ef91980b521ba4025ee98b2093"><gtr:id>26e2b0ef91980b521ba4025ee98b2093</gtr:id><gtr:otherNames>Meng B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>pm_12906_26_23305486</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51E40031-AC63-43CD-909F-BF2CAEDF17AA</gtr:id><gtr:title>Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c4df4241d0e1193d5aeffe9e19aab3d"><gtr:id>1c4df4241d0e1193d5aeffe9e19aab3d</gtr:id><gtr:otherNames>Yang J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn><gtr:outcomeId>guSgxesYRVF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2648B19C-A473-459A-A3AF-B2A0DF709FBA</gtr:id><gtr:title>Three-dimensional RNA structure of the major HIV-1 packaging signal region.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9cf535aa7f0ef15eded27945b993d6a"><gtr:id>e9cf535aa7f0ef15eded27945b993d6a</gtr:id><gtr:otherNames>Stephenson JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>pm_12906_26_23685210</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA769EBD-9766-464D-B587-8D1017221564</gtr:id><gtr:title>Optimal packaging of FIV genomic RNA depends upon a conserved long-range interaction and a palindromic sequence within gag.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62c654bae84e3e6d943bbaaf408228e7"><gtr:id>62c654bae84e3e6d943bbaaf408228e7</gtr:id><gtr:otherNames>Rizvi TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>TVe4ZrDcgAw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD296507-B054-4367-83F8-6628F000687D</gtr:id><gtr:title>Coordination of Genomic RNA Packaging with Viral Assembly in HIV-1.</gtr:title><gtr:parentPublicationTitle>Viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60b0c964f7b22a3765a52b9242093846"><gtr:id>60b0c964f7b22a3765a52b9242093846</gtr:id><gtr:otherNames>Hellmund C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1999-4915</gtr:issn><gtr:outcomeId>58aeb745bc6a42.69046735</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C2E303F-C739-412C-B8FC-2B9E870152FF</gtr:id><gtr:title>Immune adaptor ADAP in T cells regulates HIV-1 transcription and cell-cell viral spread via different co-receptors.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9dbce09b1215cc9cb72f4ef7bfe8a577"><gtr:id>9dbce09b1215cc9cb72f4ef7bfe8a577</gtr:id><gtr:otherNames>Wei B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>pm_12906_26_24047317</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8C5BAB8-738F-44DB-B69F-764BD5686835</gtr:id><gtr:title>Intracellular defenses against HIV, viral evasion and novel therapeutic approaches.</gtr:title><gtr:parentPublicationTitle>Journal of the Formosan Medical Association = Taiwan yi zhi</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e36adfe00d4c2a3aba963588cb32cd3b"><gtr:id>e36adfe00d4c2a3aba963588cb32cd3b</gtr:id><gtr:otherNames>Lever RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0929-6646</gtr:issn><gtr:outcomeId>pm_12906_26_21741003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24805BCB-15F4-458D-B1C4-B47849D04548</gtr:id><gtr:title>Identification of RNA helicases in human immunodeficiency virus 1 (HIV-1) replication - a targeted small interfering RNA library screen using pseudotyped and WT HIV-1.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca92230e3eed46bdf2d751dad9cec52f"><gtr:id>ca92230e3eed46bdf2d751dad9cec52f</gtr:id><gtr:otherNames>Williams CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>56cf3c7d9e7ae8.39128000</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC623475-E1E5-42CF-9761-C82BF7E8639C</gtr:id><gtr:title>Rev: beyond nuclear export.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1967f1ef6807f4bedadc0b6799a69e9a"><gtr:id>1967f1ef6807f4bedadc0b6799a69e9a</gtr:id><gtr:otherNames>Groom HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>pm_12906_16_19321757</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800142</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>